Vertex Pharmaceuticals Incorporated (VX1)
XETR
Closed
Aug 24, 2026
Day's Range
469.9552 wk Range
320.75Overview - VX1 - Vertex Pharmaceuticals Incorporated
Key Statistics
Valuation
Enterprise Value
97.42B
P/E (Trailing)
‪32.15‬
PEG Ratio
‪4.03‬
Price / Sales (TTM)
‪9.50‬
Price / Book
‪6.90‬
EV / EBITDA
‪22.30‬
Profitability
Gross Margin
‪85.32%‬
Profit Margin
‪34.99%‬
Operating Margin
‪38.05%‬
Return on Assets
‪11.92%‬
Return on Equity
‪23.54%‬
Ownership
Shares Outstanding
253.34M
Float
252.68M
Held by Insiders
‪0.21%‬
Held by Institutions
‪98.12%‬
Price stats
Beta
‪0.30‬
50-Day Avg
‪429.53‬
200-Day Avg
‪397.21‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - VX1 - Vertex Pharmaceuticals Incorporated
Peers - VX1 - Vertex Pharmaceuticals Incorporated
Peer Comparison
Compared with companies in Biotechnology listed on XETR.
- VX1XETRVertex Pharmaceuticals Incorporated118.74BMarket Cap+27.26%52-week change30.65P/E (Trailing)‪34.99%‬Profit Margin
- ANLXETRAnalog Devices, Inc.156.54BMarket Cap+34.61%52-week change44.45P/E (Trailing)‪29.78%‬Profit Margin
- 0QFXETRModerna, Inc.51.94BMarket Cap+83.00%52-week change-17.92P/E (Trailing)‪-141.42%‬Profit Margin
- 22UAXETRBioNTech SE25.54BMarket Cap+10.67%52-week change157.87P/E (Trailing)‪-63.63%‬Profit Margin
- BBZAXETRBB Biotech AG3.28BMarket Cap+41.60%52-week change13.32P/E (Trailing)‪127.31%‬Profit Margin
- B72XETRAtaiBeckley Inc.2.39BMarket Cap+46.88%52-week change-2.22P/E (Trailing)‪0.00%‬Profit Margin
- BV3XETRBavarian Nordic A/S1.81BMarket Cap+6.58%52-week change11.74P/E (Trailing)‪19.70%‬Profit Margin
Profile Summary - VX1 - Vertex Pharmaceuticals Incorporated
About
Vertex Pharmaceuticals Incorporated is a global biotechnology company focused on discovering, developing, manufacturing, and commercializing transformative medicines for serious diseases. The company is best known for its leadership in cystic fibrosis, where it markets a portfolio of CFTR modulator therapies such as…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
